LORLATINIB

LORLATINIB was reported 7455 times

LORLATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 17 0.6538
1 RETRO-ORBITAL NEOPLASM 17 0.3208
2 NEUROBLASTOMA RECURRENT 18 0.0887
3 MEAN ARTERIAL PRESSURE INCREASED 6 0.0857
4 BRAIN RADIATION NECROSIS 6 0.0811
5 VERY LOW DENSITY LIPOPROTEIN INCREASED 17 0.0766
6 LIPIDS ABNORMAL 47 0.0649
7 BODY SURFACE AREA INCREASED 7 0.0543
8 NON-SMALL CELL LUNG CANCER METASTATIC 37 0.0421
9 LIPIDS INCREASED 83 0.0411
10 NEUROBLASTOMA 14 0.0366
11 MALIGNANT NEOPLASM OLIGOPROGRESSION 7 0.0352
12 RADIATION NECROSIS 19 0.0332
13 METASTASES TO OESOPHAGUS 3 0.0319
14 INFANT IRRITABILITY 3 0.0306
15 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 2 0.0303
16 ALBUMIN GLOBULIN RATIO INCREASED 4 0.0292
17 THROMBOPHLEBITIS MIGRANS 8 0.0235
18 PSEUDOCELLULITIS 5 0.0234
19 HYPERTRIGLYCERIDAEMIA 130 0.0222
20 PORIOMANIA 4 0.0209
21 HYPERCHOLESTEROLAEMIA 195 0.0202
22 ENDOCARDITIS NONINFECTIVE 3 0.0201
23 BODY MASS INDEX INCREASED 26 0.0192
24 GLOBULINS INCREASED 7 0.0192
25 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 5 0.0185
26 DYSLIPIDAEMIA 91 0.0179
27 NEOPLASM PROGRESSION 620 0.0178
28 PLEURAL THICKENING 12 0.0175
29 HYPERLIPIDAEMIA 198 0.0166
30 WAIST CIRCUMFERENCE INCREASED 16 0.0154
31 CEREBRAL AMYLOID ANGIOPATHY 5 0.0152
32 SUSPECTED OFF LABEL USE 66 0.0146
33 HALLUCINATION, OLFACTORY 6 0.0138
34 NON-SMALL CELL LUNG CANCER STAGE IV 5 0.0137
35 LOW DENSITY LIPOPROTEIN INCREASED 104 0.0134
36 HYDROTHORAX 11 0.0133
37 METASTASES TO HEART 4 0.0132
38 LUNG ADENOCARCINOMA STAGE IV 5 0.0131
39 DISORGANISED SPEECH 22 0.0119
40 BLOOD TRIGLYCERIDES INCREASED 194 0.0110
41 NON-SMALL CELL LUNG CANCER 51 0.0106
42 VASCULAR ENCEPHALOPATHY 3 0.0106
43 METASTASES TO CENTRAL NERVOUS SYSTEM 135 0.0105
44 TUMOUR ASSOCIATED FEVER 4 0.0098
45 ADENOCARCINOMA METASTATIC 2 0.0097
46 CARCINOEMBRYONIC ANTIGEN INCREASED 18 0.0093
47 EOSINOPHIL PERCENTAGE INCREASED 5 0.0092
48 CHYLOTHORAX 6 0.0083
49 BLOOD CHOLESTEROL INCREASED 381 0.0082
50 BLOOD BILIRUBIN DECREASED 5 0.0081
51 BLOOD TRIGLYCERIDES ABNORMAL 7 0.0080
52 INTRACRANIAL TUMOUR HAEMORRHAGE 3 0.0078
53 METAPNEUMOVIRUS INFECTION 6 0.0077
54 LUNG ADENOCARCINOMA 23 0.0076
55 PERSECUTORY DELUSION 19 0.0076
56 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 12 0.0075
57 HALLUCINATION, AUDITORY 118 0.0074
58 EXECUTIVE DYSFUNCTION 4 0.0074
59 METASTASES TO THE MEDIASTINUM 3 0.0073
60 ACUTE PSYCHOSIS 18 0.0073
61 METASTASES TO SPINE 24 0.0071
62 GLIOSIS 3 0.0070
63 FAT TISSUE INCREASED 10 0.0069
64 MUTISM 10 0.0069
65 THYROID HORMONES INCREASED 7 0.0067
66 MEAN PLATELET VOLUME INCREASED 4 0.0066
67 TYPE V HYPERLIPIDAEMIA 3 0.0062
68 HIGH DENSITY LIPOPROTEIN INCREASED 6 0.0060
69 LANGUAGE DISORDER 13 0.0060
70 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 3 0.0060
71 HALLUCINATION 447 0.0059
72 PSYCHOTIC SYMPTOM 12 0.0058
73 SLOW SPEECH 14 0.0058
74 THYROXINE INCREASED 4 0.0057
75 MONOCYTE PERCENTAGE INCREASED 4 0.0056
76 NEUTROPHIL PERCENTAGE INCREASED 7 0.0055
77 METASTASES TO KIDNEY 3 0.0054
78 SECOND PRIMARY MALIGNANCY 45 0.0054
79 REPETITIVE SPEECH 3 0.0053
80 DYSPRAXIA 3 0.0053
81 ELECTROCARDIOGRAM PR PROLONGATION 4 0.0052
82 HALLUCINATION, VISUAL 110 0.0052
83 ASPIRATION PLEURAL CAVITY 4 0.0052
84 OEDEMA 280 0.0052
85 AMYLASE INCREASED 19 0.0051
86 ADRENAL GLAND CANCER 2 0.0051
87 NERVE BLOCK 3 0.0051
88 VITAMIN B12 INCREASED 4 0.0050
89 NEUROPSYCHOLOGICAL SYMPTOMS 3 0.0050
90 TENSION 30 0.0049
91 PANCREATIC CARCINOMA METASTATIC 14 0.0049
92 LOW DENSITY LIPOPROTEIN ABNORMAL 3 0.0049
93 CARDIOPULMONARY FAILURE 19 0.0049
94 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 3 0.0048
95 METASTASES TO MENINGES 11 0.0048
96 HIGH DENSITY LIPOPROTEIN DECREASED 16 0.0048
97 BLOOD CREATININE DECREASED 15 0.0048
98 BLOOD CHOLESTEROL ABNORMAL 22 0.0048
99 MALIGNANT PLEURAL EFFUSION 8 0.0047
100 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
101 SOLILOQUY 4 0.0046
102 HYPERCHLORHYDRIA 27 0.0046
103 PERIPHERAL NERVE INJURY 4 0.0046
104 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 3 0.0046
105 COGNITIVE DISORDER 206 0.0044
106 PERICARDIAL EFFUSION 100 0.0043
107 POSITRON EMISSION TOMOGRAM ABNORMAL 3 0.0043
108 HALLUCINATIONS, MIXED 18 0.0043
109 WHITE BLOOD CELLS URINE POSITIVE 8 0.0042
110 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 7 0.0042
111 BLOOD THYROID STIMULATING HORMONE INCREASED 38 0.0041
112 PULMONARY PAIN 12 0.0041
113 AFFECTIVE DISORDER 32 0.0041
114 GENE MUTATION 8 0.0040
115 VARICES OESOPHAGEAL 12 0.0040
116 BRAIN OPERATION 9 0.0039
117 CREATINE KINASE INCREASED 3 0.0039
118 LYMPHANGIOSIS CARCINOMATOSA 4 0.0038
119 TUMOUR PAIN 5 0.0038
120 METABOLIC SYNDROME 6 0.0036
121 MYOCARDIAL INJURY 4 0.0036
122 NERVOUS SYSTEM DISORDER 111 0.0036
123 PSYCHIATRIC SYMPTOM 26 0.0035
124 LAZINESS 6 0.0035
125 LUNG CANCER METASTATIC 10 0.0035
126 PULMONARY TOXICITY 24 0.0034
127 NEPHROTIC SYNDROME 23 0.0034
128 BRAIN OEDEMA 42 0.0033
129 SMALL CELL LUNG CANCER 5 0.0033
130 SELECTIVE EATING DISORDER 3 0.0033
131 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
132 METASTASES TO LYMPH NODES 22 0.0033
133 METASTASES TO ADRENALS 3 0.0033
134 MEAN CELL VOLUME DECREASED 5 0.0032
135 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4 0.0032
136 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
137 GLUCOSE URINE PRESENT 4 0.0031
138 PLEURAL EFFUSION 191 0.0031
139 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
140 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
141 RED BLOOD CELLS URINE POSITIVE 3 0.0031
142 EARLY SATIETY 6 0.0031
143 LUNG OPACITY 8 0.0030
144 LYMPHOCYTE PERCENTAGE DECREASED 4 0.0030
145 METASTASES TO LIVER 52 0.0030
146 SLEEP TALKING 5 0.0029
147 PSYCHOTIC DISORDER 85 0.0029
148 PNEUMONITIS 78 0.0029
149 METASTASES TO PLEURA 3 0.0029
150 FULL BLOOD COUNT ABNORMAL 30 0.0028
151 HYDROCELE 3 0.0028
152 CEREBRAL ARTERY OCCLUSION 3 0.0028
153 TRACHEOSTOMY 4 0.0028
154 MALIGNANT NEOPLASM PROGRESSION 285 0.0028
155 HYPERPHAGIA 11 0.0028
156 CARPAL TUNNEL SYNDROME 38 0.0027
157 PERIPHERAL ISCHAEMIA 11 0.0027
158 BLOOD PRESSURE DIASTOLIC INCREASED 12 0.0026
159 GENERALISED OEDEMA 32 0.0026
160 CARDIAC TAMPONADE 12 0.0025
161 EMPYEMA 5 0.0025
162 CEREBRAL ATROPHY 10 0.0025
163 LARGE INTESTINAL STENOSIS 5 0.0025
164 BRAIN FOG 39 0.0025
165 OPTIC ATROPHY 4 0.0025
166 CARDIAC DYSFUNCTION 9 0.0024
167 MYOCARDIAL NECROSIS MARKER INCREASED 4 0.0024
168 MOOD ALTERED 65 0.0024
169 OPTIC NEUROPATHY 5 0.0024
170 HEPATIC INFECTION 3 0.0023
171 BLOOD CHLORIDE INCREASED 4 0.0023
172 BILIARY OBSTRUCTION 3 0.0023
173 LYMPHOEDEMA 16 0.0023
174 CEREBRAL DISORDER 17 0.0023
175 ACQUIRED GENE MUTATION 3 0.0023
176 POLYNEUROPATHY 27 0.0023
177 VOCAL CORD PARALYSIS 4 0.0022
178 NEUROPATHY PERIPHERAL 212 0.0022
179 BEHAVIOUR DISORDER 12 0.0022
180 OEDEMA PERIPHERAL 270 0.0022
181 PROTEIN URINE PRESENT 11 0.0022
182 HEPATIC LESION 9 0.0021
183 DYSPNOEA AT REST 6 0.0021
184 GLYCOSYLATED HAEMOGLOBIN INCREASED 52 0.0021
185 NERVE COMPRESSION 19 0.0021
186 NEUROTOXICITY 36 0.0021
187 PSYCHIATRIC DECOMPENSATION 4 0.0020
188 NORMOCYTIC ANAEMIA 3 0.0020
189 RESPIRATORY RATE INCREASED 18 0.0020
190 HYPERTRANSAMINASAEMIA 14 0.0020
191 WEIGHT FLUCTUATION 21 0.0020
192 SPEECH DISORDER 105 0.0020
193 INFECTIOUS PLEURAL EFFUSION 3 0.0020
194 METASTASIS 14 0.0020
195 CANCER PAIN 5 0.0020
196 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
197 PERSONALITY CHANGE 18 0.0019
198 GASTROSTOMY 3 0.0019
199 WEIGHT INCREASED 433 0.0019
200 NEUROLOGICAL SYMPTOM 11 0.0019
201 ENTEROCOLITIS 11 0.0019
202 BLOOD URIC ACID INCREASED 11 0.0019
203 DISINHIBITION 3 0.0019
204 METASTASES TO LUNG 21 0.0018
205 IGA NEPHROPATHY 3 0.0018
206 GASTRIC DILATATION 3 0.0018
207 BACTERIAL TEST POSITIVE 4 0.0018
208 VENOUS THROMBOSIS 7 0.0018
209 INCREASED APPETITE 34 0.0018
210 DYSPHORIA 9 0.0018
211 NEOPLASM RECURRENCE 6 0.0018
212 READING DISORDER 4 0.0017
213 MENTAL DISORDER 76 0.0017
214 VITAMIN B12 DECREASED 5 0.0017
215 NEUROLOGICAL DECOMPENSATION 4 0.0017
216 DEATH 1486 0.0017
217 GAIT INABILITY 57 0.0017
218 LOGORRHOEA 6 0.0017
219 DYSPNOEA EXERTIONAL 64 0.0017
220 PARAPARESIS 3 0.0017
221 WEIGHT ABNORMAL 4 0.0017
222 BONE LESION 6 0.0017
223 HUNGER 23 0.0016
224 METASTASES TO BONE 27 0.0016
225 DRUG RESISTANCE 42 0.0016
226 CHEST X-RAY ABNORMAL 5 0.0016
227 NECROSIS 9 0.0016
228 SUFFOCATION FEELING 4 0.0016
229 HEPATIC ENZYME ABNORMAL 8 0.0016
230 DELIRIUM 55 0.0016
231 HYPOPROTEINAEMIA 3 0.0016
232 RADIOTHERAPY 3 0.0016
233 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
234 CEREBRAL INFARCTION 38 0.0016
235 AORTIC ARTERIOSCLEROSIS 4 0.0016
236 HAEMOPTYSIS 43 0.0015
237 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
238 HYPOGEUSIA 3 0.0015
239 JOINT NOISE 3 0.0015
240 VITAMIN D DECREASED 13 0.0015
241 ANGER 51 0.0015
242 PERIPHERAL SWELLING 229 0.0015
243 MEMORY IMPAIRMENT 204 0.0015
244 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 5 0.0015
245 DELUSION 23 0.0015
246 HYDROCEPHALUS 8 0.0015
247 FAECALOMA 8 0.0015
248 IMPULSE-CONTROL DISORDER 3 0.0015
249 GASTROINTESTINAL TOXICITY 7 0.0015
250 APHASIA 44 0.0015
251 PLEURITIC PAIN 4 0.0014
252 THYROID FUNCTION TEST ABNORMAL 6 0.0014
253 ALTERED STATE OF CONSCIOUSNESS 31 0.0014
254 ELECTRIC SHOCK SENSATION 4 0.0014
255 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
256 NEUROGENIC BLADDER 3 0.0014
257 JAUNDICE CHOLESTATIC 5 0.0014
258 CEREBRAL THROMBOSIS 4 0.0014
259 OESOPHAGEAL STENOSIS 4 0.0014
260 RADIATION PNEUMONITIS 3 0.0014
261 TUMOUR HAEMORRHAGE 4 0.0014
262 BLOOD ALBUMIN DECREASED 11 0.0014
263 MONOCYTE COUNT INCREASED 5 0.0014
264 MAJOR DEPRESSION 10 0.0014
265 NEGATIVE THOUGHTS 4 0.0014
266 PULMONARY OEDEMA 61 0.0014
267 ASCITES 40 0.0014
268 PLEURISY 8 0.0013
269 IRRITABILITY 81 0.0013
270 ATELECTASIS 13 0.0013
271 THINKING ABNORMAL 25 0.0013
272 ANAL INCONTINENCE 12 0.0013
273 FOOD CRAVING 7 0.0013
274 DYSARTHRIA 50 0.0013
275 HYPERCAPNIA 4 0.0013
276 PROTEIN TOTAL DECREASED 5 0.0013
277 AUTOIMMUNE THYROIDITIS 5 0.0013
278 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
279 DISEASE PROGRESSION 155 0.0013
280 BRAIN NEOPLASM 12 0.0013
281 RESPIRATION ABNORMAL 9 0.0013
282 PANCREATITIS NECROTISING 3 0.0013
283 DYSAESTHESIA 4 0.0013
284 HAEMOGLOBIN DECREASED 134 0.0013
285 ENCEPHALITIS 9 0.0013
286 DECREASED ACTIVITY 14 0.0013
287 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
288 RENAL FUNCTION TEST ABNORMAL 6 0.0013
289 ELECTROCARDIOGRAM QT PROLONGED 46 0.0013
290 PARALYSIS 18 0.0013
291 MOOD SWINGS 40 0.0013
292 TUMOUR MARKER INCREASED 6 0.0012
293 SENSORY LOSS 10 0.0012
294 PANNICULITIS 3 0.0012
295 PERIPHERAL VENOUS DISEASE 5 0.0012
296 TRIGGER FINGER 5 0.0012
297 CARDIOMEGALY 15 0.0012
298 CEREBRAL HAEMORRHAGE 43 0.0012
299 LUNG NEOPLASM MALIGNANT 49 0.0012
300 LIPASE INCREASED 9 0.0012
301 PULMONARY EMBOLISM 111 0.0012
302 CEREBRAL ISCHAEMIA 6 0.0012
303 BLOOD CHLORIDE DECREASED 3 0.0012
304 LEUKOCYTOSIS 21 0.0012
305 JOINT EFFUSION 8 0.0012
306 HYPOTHYROIDISM 37 0.0012
307 GRANULOMA 4 0.0012
308 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
309 COORDINATION ABNORMAL 16 0.0011
310 DYSPHEMIA 5 0.0011
311 PERICARDITIS 19 0.0011
312 THROMBOTIC MICROANGIOPATHY 11 0.0011
313 HEPATOTOXICITY 25 0.0011
314 HEMIPARESIS 19 0.0011
315 LIVER FUNCTION TEST INCREASED 24 0.0011
316 CHONDROPATHY 3 0.0011
317 PAPILLOEDEMA 5 0.0011
318 PULMONARY HYPERTENSION 23 0.0011
319 SUBDURAL HAEMORRHAGE 3 0.0011
320 MANIA 18 0.0011
321 FULL BLOOD COUNT DECREASED 22 0.0011
322 LOCALISED OEDEMA 5 0.0011
323 LEUKOENCEPHALOPATHY 4 0.0011
324 HYDRONEPHROSIS 8 0.0011
325 HYPERBILIRUBINAEMIA 11 0.0011
326 FLUID RETENTION 54 0.0011
327 APPETITE DISORDER 7 0.0011
328 SLEEP DISORDER 74 0.0010
329 MENINGITIS 7 0.0010
330 GAMMA-GLUTAMYLTRANSFERASE INCREASED 23 0.0010
331 ATRIOVENTRICULAR BLOCK 8 0.0010
332 HYPOALBUMINAEMIA 8 0.0010
333 SPINAL CORD COMPRESSION 4 0.0010
334 INFARCTION 7 0.0010
335 DRUG-INDUCED LIVER INJURY 32 0.0010
336 ENERGY INCREASED 6 0.0010
337 ASPARTATE AMINOTRANSFERASE INCREASED 54 0.0010
338 DISORIENTATION 40 0.0010
339 CARDIOTOXICITY 9 0.0010
340 URINE ANALYSIS ABNORMAL 3 0.0010
341 PROTEINURIA 19 0.0010
342 CARDIAC FAILURE 80 0.0010
343 INTRACRANIAL ANEURYSM 4 0.0010
344 MENTAL IMPAIRMENT 24 0.0010
345 PATHOLOGICAL FRACTURE 5 0.0010
346 RECURRENT CANCER 4 0.0010
347 MASTICATION DISORDER 3 0.0010
348 SUBDURAL HAEMATOMA 14 0.0010
349 DIASTOLIC DYSFUNCTION 3 0.0010
350 VISUAL FIELD DEFECT 7 0.0010
351 MULTIPLE-DRUG RESISTANCE 3 0.0010
352 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
353 HEPATIC STEATOSIS 18 0.0010
354 HEMIPLEGIA 8 0.0010
355 BLOOD UREA INCREASED 16 0.0010
356 HYPERPYREXIA 4 0.0009
357 SCREAMING 6 0.0009
358 HYPERSOMNIA 27 0.0009
359 PNEUMONIA VIRAL 3 0.0009
360 POOR PERIPHERAL CIRCULATION 4 0.0009
361 AFFECT LABILITY 9 0.0009
362 VENTRICULAR HYPOKINESIA 3 0.0009
363 METASTATIC NEOPLASM 4 0.0009
364 BLOOD IRON DECREASED 11 0.0009
365 INCOHERENT 6 0.0009
366 ATAXIA 11 0.0009
367 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
368 BLOOD CREATININE INCREASED 60 0.0009
369 HEPATOMEGALY 9 0.0009
370 PANCYTOPENIA 51 0.0009
371 HEPATIC FUNCTION ABNORMAL 34 0.0009
372 ABDOMINAL DISTENSION 95 0.0009
373 HAEMATOCRIT DECREASED 18 0.0009
374 HYPERGLYCAEMIA 33 0.0009
375 ANXIETY DISORDER 3 0.0009
376 CONFUSIONAL STATE 145 0.0009
377 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
378 JOINT RANGE OF MOTION DECREASED 12 0.0009
379 TINNITUS 41 0.0009
380 MACULAR OEDEMA 5 0.0009
381 FACE OEDEMA 15 0.0009
382 IRON DEFICIENCY 4 0.0009
383 MOTOR DYSFUNCTION 9 0.0009
384 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
385 DIABETES MELLITUS 67 0.0009
386 EUPHORIC MOOD 9 0.0009
387 DISEASE COMPLICATION 4 0.0009
388 PNEUMONIA BACTERIAL 8 0.0009
389 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
390 BLOOD CREATININE ABNORMAL 3 0.0009
391 IRON DEFICIENCY ANAEMIA 8 0.0009
392 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
393 SPINAL PAIN 10 0.0009
394 DEPRESSIVE SYMPTOM 3 0.0009
395 DECREASED INTEREST 5 0.0008
396 HEAD DISCOMFORT 15 0.0008
397 FLATULENCE 48 0.0008
398 FIBRIN D DIMER INCREASED 3 0.0008
399 PLATELET COUNT INCREASED 11 0.0008
400 CONJUNCTIVAL HYPERAEMIA 3 0.0008
401 EOSINOPHIL COUNT INCREASED 7 0.0008
402 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
403 AMNESIA 54 0.0008
404 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
405 HEART RATE INCREASED 81 0.0008
406 EMOTIONAL DISORDER 25 0.0008
407 MUSCLE STRAIN 7 0.0008
408 HYPERACUSIS 3 0.0008
409 BLOOD POTASSIUM INCREASED 13 0.0008
410 ERYSIPELAS 4 0.0008
411 SNORING 3 0.0008
412 IMMUNOSUPPRESSION 7 0.0008
413 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
414 SWELLING 74 0.0008
415 EPILEPSY 24 0.0008
416 COMMUNICATION DISORDER 3 0.0008
417 GASTRIC INFECTION 3 0.0008
418 ABDOMINAL INFECTION 2 0.0008
419 WEIGHT LOSS POOR 4 0.0008
420 HAEMOLYTIC ANAEMIA 7 0.0008
421 DISTURBANCE IN ATTENTION 42 0.0008
422 RHINOVIRUS INFECTION 3 0.0008
423 RESPIRATORY DISORDER 23 0.0008
424 RENAL IMPAIRMENT 64 0.0008
425 CARDIAC FAILURE ACUTE 5 0.0007
426 FOOD POISONING 4 0.0007
427 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
428 ORGAN FAILURE 3 0.0007
429 BLOOD SODIUM DECREASED 14 0.0007
430 HOMICIDAL IDEATION 3 0.0007
431 FEEDING DISORDER 15 0.0007
432 ABDOMINAL RIGIDITY 2 0.0007
433 DECUBITUS ULCER 6 0.0007
434 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
435 ALANINE AMINOTRANSFERASE INCREASED 45 0.0007
436 GOITRE 3 0.0007
437 HYPERURICAEMIA 3 0.0007
438 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
439 AORTIC DISSECTION 3 0.0007
440 ABNORMAL DREAMS 20 0.0007
441 HAIR GROWTH ABNORMAL 5 0.0007
442 SUICIDAL BEHAVIOUR 3 0.0007
443 AGGRESSION 36 0.0007
444 BLOOD PRESSURE INCREASED 109 0.0007
445 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
446 AORTIC VALVE INCOMPETENCE 3 0.0007
447 FACIAL PARALYSIS 6 0.0007
448 PULMONARY TUBERCULOSIS 3 0.0007
449 DEPRESSED MOOD 37 0.0007
450 PALLOR 19 0.0007
451 PARANOIA 12 0.0007
452 PNEUMOTHORAX 11 0.0007
453 NIGHTMARE 24 0.0007
454 MONOPLEGIA 3 0.0007
455 BONE CANCER 3 0.0007
456 APATHY 10 0.0007
457 MENTAL STATUS CHANGES 19 0.0007
458 DYSPHONIA 40 0.0007
459 NEUTROPHIL COUNT INCREASED 7 0.0007
460 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
461 URINARY INCONTINENCE 20 0.0007
462 CHOLECYSTITIS 8 0.0007
463 BRAIN NEOPLASM MALIGNANT 3 0.0007
464 PAROSMIA 5 0.0007
465 INTERSTITIAL LUNG DISEASE 32 0.0007
466 THROMBOSIS 53 0.0007
467 NEURALGIA 16 0.0007
468 EAR DISORDER 3 0.0007
469 LIVER DISORDER 29 0.0007
470 LIVER INJURY 16 0.0007
471 THYROID DISORDER 10 0.0006
472 PIGMENTATION DISORDER 4 0.0006
473 MUSCULOSKELETAL CHEST PAIN 10 0.0006
474 RESPIRATORY FAILURE 47 0.0006
475 FEELING OF DESPAIR 3 0.0006
476 PERFORMANCE STATUS DECREASED 3 0.0006
477 APPENDICITIS 6 0.0006
478 HYPOAESTHESIA 96 0.0006
479 THERAPY PARTIAL RESPONDER 10 0.0006
480 TASTE DISORDER 13 0.0006
481 PULMONARY HAEMORRHAGE 5 0.0006
482 PHOTOPSIA 4 0.0006
483 MUSCULOSKELETAL STIFFNESS 55 0.0006
484 MOBILITY DECREASED 45 0.0006
485 OXYGEN SATURATION DECREASED 35 0.0006
486 BLOOD CALCIUM DECREASED 7 0.0006
487 HYPERTHYROIDISM 9 0.0006
488 DYSPHAGIA 59 0.0006
489 VISUAL IMPAIRMENT 76 0.0006
490 BREATH SOUNDS ABNORMAL 3 0.0006
491 ORGANISING PNEUMONIA 3 0.0006
492 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
493 BALANCE DISORDER 52 0.0006
494 RESTLESSNESS 22 0.0006
495 PNEUMONIA ASPIRATION 15 0.0006
496 GENERAL PHYSICAL HEALTH DETERIORATION 69 0.0006
497 FEAR 16 0.0006
498 MOVEMENT DISORDER 19 0.0006
499 PHLEBITIS 3 0.0006
500 EJECTION FRACTION DECREASED 9 0.0006
501 FORMICATION 4 0.0006
502 EXTRASYSTOLES 4 0.0006
503 PARTIAL SEIZURES 3 0.0006
504 BLOOD GLUCOSE INCREASED 107 0.0006
505 HYPERCALCAEMIA 7 0.0006
506 LYMPHADENOPATHY 20 0.0006
507 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
508 BREAST PAIN 6 0.0006
509 SENSORY DISTURBANCE 9 0.0006
510 JAUNDICE 15 0.0006
511 IMPAIRED QUALITY OF LIFE 8 0.0006
512 MUSCLE TIGHTNESS 9 0.0006
513 ABNORMAL BEHAVIOUR 22 0.0006
514 DEEP VEIN THROMBOSIS 36 0.0006
515 PLATELET COUNT DECREASED 59 0.0006
516 SWELLING FACE 36 0.0006
517 MUSCLE ATROPHY 7 0.0006
518 LIVER FUNCTION TEST ABNORMAL 16 0.0005
519 TIC 3 0.0005
520 FAECES SOFT 4 0.0005
521 JAW DISORDER 3 0.0005
522 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
523 PARAESTHESIA 86 0.0005
524 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
525 BLOOD GLUCOSE ABNORMAL 10 0.0005
526 CARDIOMYOPATHY 8 0.0005
527 BLINDNESS 22 0.0005
528 INTRACRANIAL PRESSURE INCREASED 3 0.0005
529 FEELING DRUNK 4 0.0005
530 HEART RATE ABNORMAL 3 0.0005
531 PULMONARY MASS 8 0.0005
532 CONSTIPATION 117 0.0005
533 ASTHENIA 200 0.0005
534 SKIN TOXICITY 3 0.0005
535 PERIORBITAL SWELLING 3 0.0005
536 ENCEPHALOPATHY 13 0.0005
537 TROPONIN INCREASED 4 0.0005
538 OFF LABEL USE 457 0.0005
539 ACUTE RESPIRATORY FAILURE 10 0.0005
540 BLOOD BILIRUBIN INCREASED 14 0.0005
541 DYSPNOEA 293 0.0005
542 METABOLIC DISORDER 3 0.0005
543 EATING DISORDER 11 0.0005
544 STRESS CARDIOMYOPATHY 3 0.0005
545 DYSSTASIA 15 0.0005
546 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
547 URINE ODOUR ABNORMAL 3 0.0005
548 VITREOUS FLOATERS 5 0.0005
549 THERAPY CHANGE 5 0.0005
550 BRADYKINESIA 3 0.0005
551 BODY TEMPERATURE DECREASED 5 0.0005
552 LOWER RESPIRATORY TRACT INFECTION 23 0.0005
553 JOINT SWELLING 61 0.0005
554 RENAL CYST 4 0.0005
555 CARDIAC PACEMAKER INSERTION 3 0.0005
556 OBESITY 8 0.0005
557 PROTHROMBIN TIME PROLONGED 3 0.0005
558 APHONIA 7 0.0005
559 BLOOD DISORDER 4 0.0005
560 COUGH 140 0.0005
561 DEAFNESS 13 0.0005
562 GAIT DISTURBANCE 95 0.0005
563 FRUSTRATION TOLERANCE DECREASED 4 0.0005
564 TRANSAMINASES INCREASED 11 0.0005
565 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
566 BONE DISORDER 9 0.0005
567 SCHIZOPHRENIA 6 0.0005
568 SEIZURE 57 0.0005
569 DERMATITIS ACNEIFORM 3 0.0005
570 EYELID PTOSIS 5 0.0005
571 GASTROINTESTINAL DISORDER 44 0.0005
572 INTENTIONAL DOSE OMISSION 14 0.0005
573 LUNG DISORDER 24 0.0005
574 RED BLOOD CELL COUNT DECREASED 14 0.0005
575 POLYURIA 4 0.0005
576 PNEUMONIA 158 0.0005
577 HICCUPS 4 0.0005
578 ARRHYTHMIA 23 0.0005
579 LIMB DISCOMFORT 15 0.0005
580 OLIGURIA 3 0.0005
581 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
582 PRODUCTIVE COUGH 23 0.0005
583 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
584 AGITATION 35 0.0005
585 DISCOMFORT 29 0.0005
586 PAIN IN EXTREMITY 140 0.0005
587 MUSCULAR WEAKNESS 54 0.0005
588 PANCREATITIS 25 0.0005
589 IMPAIRED WORK ABILITY 10 0.0005
590 CRYING 17 0.0005
591 SKIN HYPERPIGMENTATION 4 0.0005
592 POOR QUALITY SLEEP 10 0.0005
593 MYOPATHY 4 0.0005
594 PRODUCT PRESCRIBING ERROR 11 0.0005
595 PYELONEPHRITIS 4 0.0005
596 NERVOUSNESS 24 0.0005
597 BRADYPHRENIA 3 0.0005
598 ASPERGILLUS INFECTION 3 0.0005
599 DYSGRAPHIA 3 0.0005
600 DEVICE RELATED INFECTION 7 0.0005
601 ANXIETY 129 0.0005
602 BRADYCARDIA 24 0.0005
603 NERVE INJURY 5 0.0004
604 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
605 THROMBOCYTOPENIA 50 0.0004
606 MYALGIA 76 0.0004
607 NEPHROPATHY TOXIC 5 0.0004
608 POSTOPERATIVE WOUND INFECTION 3 0.0004
609 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
610 DISEASE RECURRENCE 21 0.0004
611 TACHYPNOEA 6 0.0004
612 IMPAIRED DRIVING ABILITY 5 0.0004
613 ONYCHOCLASIS 3 0.0004
614 RESPIRATORY DISTRESS 12 0.0004
615 NIGHT SWEATS 14 0.0004
616 DROOLING 3 0.0004
617 UROSEPSIS 4 0.0004
618 HEPATIC FAILURE 13 0.0004
619 PYREXIA 149 0.0004
620 ANAEMIA 82 0.0004
621 DEMENTIA 12 0.0004
622 BLOOD TEST ABNORMAL 6 0.0004
623 CHOLELITHIASIS 14 0.0004
624 HAND FRACTURE 3 0.0004
625 SINUS TACHYCARDIA 6 0.0004
626 URINARY RETENTION 14 0.0004
627 JOINT STIFFNESS 11 0.0004
628 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
629 ACCIDENT 5 0.0004
630 HYPOACUSIS 18 0.0004
631 TYPE 2 DIABETES MELLITUS 14 0.0004
632 PANIC REACTION 3 0.0004
633 HYPERTENSION 88 0.0004
634 MYELODYSPLASTIC SYNDROME 6 0.0004
635 TONGUE DISORDER 3 0.0004
636 HYPOKINESIA 6 0.0004
637 MOUTH HAEMORRHAGE 3 0.0004
638 PHARYNGEAL SWELLING 4 0.0004
639 RENAL TUBULAR NECROSIS 4 0.0004
640 ACUTE MYOCARDIAL INFARCTION 12 0.0004
641 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
642 SENSITIVE SKIN 3 0.0004
643 AGEUSIA 10 0.0004
644 DYSPEPSIA 39 0.0004
645 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
646 NECK PAIN 22 0.0004
647 ISCHAEMIC STROKE 7 0.0004
648 FEBRILE NEUTROPENIA 26 0.0004
649 HIP ARTHROPLASTY 6 0.0004
650 BOWEL MOVEMENT IRREGULARITY 3 0.0004
651 HEPATITIS 10 0.0004
652 FOOD ALLERGY 3 0.0004
653 EPISTAXIS 29 0.0004
654 MOUTH ULCERATION 8 0.0004
655 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
656 IMMUNE SYSTEM DISORDER 5 0.0004
657 TOOTH INFECTION 5 0.0004
658 PULMONARY CONGESTION 5 0.0004
659 FURUNCLE 3 0.0004
660 DIABETIC KETOACIDOSIS 9 0.0004
661 BACK PAIN 87 0.0004
662 BODY HEIGHT DECREASED 4 0.0004
663 BURNING SENSATION 26 0.0004
664 MUSCLE DISORDER 3 0.0004
665 DEPRESSION 84 0.0004
666 HYPOXIA 13 0.0004
667 BIPOLAR DISORDER 4 0.0004
668 PULMONARY THROMBOSIS 4 0.0004
669 BLOOD GLUCOSE FLUCTUATION 4 0.0004
670 LOWER LIMB FRACTURE 7 0.0004
671 THERAPY INTERRUPTED 26 0.0004
672 CORONARY ARTERY DISEASE 11 0.0004
673 ARTHRALGIA 151 0.0004
674 MENSTRUAL DISORDER 3 0.0004
675 ACUTE CORONARY SYNDROME 3 0.0004
676 DENTAL CARIES 4 0.0004
677 EMBOLISM 3 0.0004
678 HYPERTENSIVE CRISIS 4 0.0004
679 ILLNESS 37 0.0004
680 MASS 5 0.0004
681 DECREASED APPETITE 83 0.0004
682 C-REACTIVE PROTEIN INCREASED 13 0.0004
683 INSOMNIA 95 0.0004
684 INTESTINAL PERFORATION 4 0.0004
685 OCULAR DISCOMFORT 4 0.0004
686 CEREBROVASCULAR ACCIDENT 60 0.0004
687 BLOOD PRESSURE ABNORMAL 7 0.0004
688 MYOCARDIAL ISCHAEMIA 4 0.0004
689 FATIGUE 273 0.0004
690 HAEMATURIA 12 0.0004
691 VISION BLURRED 48 0.0003
692 MUSCLE TWITCHING 8 0.0003
693 SUICIDE ATTEMPT 21 0.0003
694 ELECTROLYTE IMBALANCE 4 0.0003
695 WEIGHT DECREASED 96 0.0003
696 URINE OUTPUT DECREASED 3 0.0003
697 GROIN PAIN 3 0.0003
698 TUMOUR LYSIS SYNDROME 3 0.0003
699 FACIAL PAIN 3 0.0003
700 EYE DISORDER 11 0.0003
701 HEAVY MENSTRUAL BLEEDING 3 0.0003
702 CHEST DISCOMFORT 34 0.0003
703 HYPOAESTHESIA ORAL 5 0.0003
704 TOOTHACHE 6 0.0003
705 VIRAL INFECTION 11 0.0003
706 ARTHRITIS 26 0.0003
707 OPTIC NEURITIS 3 0.0003
708 CHEST PAIN 61 0.0003
709 OVARIAN CANCER 3 0.0003
710 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
711 OSTEONECROSIS OF JAW 8 0.0003
712 DYSGEUSIA 24 0.0003
713 EXTRAPYRAMIDAL DISORDER 8 0.0003
714 DERMATITIS ALLERGIC 4 0.0003
715 BLOOD URINE PRESENT 6 0.0003
716 CONDITION AGGRAVATED 96 0.0003
717 HAEMATEMESIS 8 0.0003
718 MUSCULOSKELETAL DISORDER 6 0.0003
719 RESPIRATORY TRACT CONGESTION 5 0.0003
720 SLEEP APNOEA SYNDROME 6 0.0003
721 ULCER 5 0.0003
722 PULMONARY FIBROSIS 6 0.0003
723 LOSS OF CONSCIOUSNESS 40 0.0003
724 PANCREATITIS ACUTE 7 0.0003
725 ROAD TRAFFIC ACCIDENT 13 0.0003
726 UNRESPONSIVE TO STIMULI 8 0.0003
727 DIZZINESS POSTURAL 3 0.0003
728 DIPLOPIA 8 0.0003
729 MUCOSAL INFLAMMATION 8 0.0003
730 RENAL FAILURE 40 0.0003
731 SALIVARY HYPERSECRETION 3 0.0003
732 SYNCOPE 30 0.0003
733 SPINAL FRACTURE 6 0.0003
734 BRAIN INJURY 3 0.0003
735 DIARRHOEA 193 0.0003
736 TOXIC SKIN ERUPTION 3 0.0003
737 DRY THROAT 3 0.0003
738 SUBARACHNOID HAEMORRHAGE 3 0.0003
739 INITIAL INSOMNIA 3 0.0003
740 COVID-19 51 0.0003
741 DRUG INTOLERANCE 28 0.0003
742 VENTRICULAR EXTRASYSTOLES 3 0.0003
743 CARDIAC DISORDER 27 0.0003
744 RHABDOMYOLYSIS 12 0.0003
745 HYPOMAGNESAEMIA 4 0.0003
746 TRANSFUSION 3 0.0003
747 INCONTINENCE 3 0.0003
748 SUDDEN DEATH 3 0.0003
749 NEPHROLITHIASIS 13 0.0003
750 LYMPHOCYTE COUNT DECREASED 5 0.0003
751 URINARY TRACT INFECTION 48 0.0003
752 THIRST 5 0.0003
753 SOMNOLENCE 56 0.0003
754 ABDOMINAL PAIN LOWER 7 0.0003
755 MENSTRUATION DELAYED 3 0.0003
756 RESTLESS LEGS SYNDROME 5 0.0003
757 OSTEONECROSIS 9 0.0003
758 BONE PAIN 16 0.0003
759 SUICIDAL IDEATION 25 0.0003
760 DIZZINESS 136 0.0003
761 TOOTH FRACTURE 3 0.0003
762 INFLAMMATION 14 0.0003
763 LABORATORY TEST ABNORMAL 8 0.0003
764 VISUAL ACUITY REDUCED 9 0.0003
765 PAIN 166 0.0003
766 INFECTION 39 0.0003
767 MALAISE 118 0.0003
768 MALNUTRITION 3 0.0003
769 BACTERIAL INFECTION 5 0.0003
770 SKIN INFECTION 3 0.0003
771 EYE INFECTION 3 0.0003
772 INTESTINAL OBSTRUCTION 10 0.0003
773 MITRAL VALVE INCOMPETENCE 3 0.0003
774 DRUG INTERACTION 42 0.0003
775 FRACTURE 5 0.0003
776 HEPATIC ENZYME INCREASED 18 0.0003
777 CHOLECYSTECTOMY 3 0.0003
778 SKIN DISCOLOURATION 12 0.0003
779 NEOPLASM 3 0.0003
780 SHOCK 6 0.0003
781 OSTEOARTHRITIS 11 0.0003
782 ERUCTATION 5 0.0003
783 EYELID OEDEMA 3 0.0003
784 HEART RATE DECREASED 9 0.0003
785 FEELING ABNORMAL 61 0.0003
786 COVID-19 PNEUMONIA 3 0.0003
787 WHEEZING 15 0.0003
788 COMA 12 0.0003
789 SCIATICA 4 0.0003
790 HEADACHE 157 0.0003
791 CARDIAC FAILURE CONGESTIVE 20 0.0002
792 HIP FRACTURE 8 0.0002
793 HYPONATRAEMIA 14 0.0002
794 LOCALISED INFECTION 6 0.0002
795 BACK DISORDER 4 0.0002
796 BODY TEMPERATURE INCREASED 5 0.0002
797 RIB FRACTURE 5 0.0002
798 ABNORMAL WEIGHT GAIN 3 0.0002
799 VENTRICULAR TACHYCARDIA 4 0.0002
800 PHOTOSENSITIVITY REACTION 4 0.0002
801 EYE SWELLING 9 0.0002
802 ILEUS 3 0.0002
803 TOOTH EXTRACTION 3 0.0002
804 INTENTIONAL PRODUCT MISUSE 21 0.0002
805 SKIN DISORDER 8 0.0002
806 RETCHING 5 0.0002
807 THERAPY CESSATION 12 0.0002
808 FALL 77 0.0002
809 NODULE 3 0.0002
810 PRODUCT DISPENSING ERROR 5 0.0002
811 FEELING HOT 14 0.0002
812 GASTRITIS 6 0.0002
813 TOOTH DISORDER 5 0.0002
814 GALLBLADDER DISORDER 4 0.0002
815 MENSTRUATION IRREGULAR 6 0.0002
816 MALIGNANT MELANOMA 3 0.0002
817 GOUT 4 0.0002
818 NASOPHARYNGITIS 41 0.0002
819 MYELOSUPPRESSION 8 0.0002
820 DYSKINESIA 9 0.0002
821 LIMB INJURY 6 0.0002
822 GINGIVAL BLEEDING 3 0.0002
823 SKIN LESION 6 0.0002
824 ARTHROPATHY 12 0.0002
825 POLLAKIURIA 9 0.0002
826 ATRIAL FIBRILLATION 21 0.0002
827 FEELING COLD 6 0.0002
828 ABDOMINAL PAIN 50 0.0002
829 VOMITING 101 0.0002
830 HOSPITALISATION 33 0.0002
831 RENAL DISORDER 10 0.0002
832 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
833 VERTIGO 13 0.0002
834 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
835 HEPATIC CIRRHOSIS 4 0.0002
836 HEPATOCELLULAR INJURY 3 0.0002
837 ANGINA PECTORIS 6 0.0002
838 ALOPECIA 41 0.0002
839 BLOOD PRESSURE FLUCTUATION 5 0.0002
840 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
841 CHOKING 4 0.0002
842 IMMUNODEFICIENCY 3 0.0002
843 RASH 87 0.0002
844 CELLULITIS 10 0.0002
845 PRODUCT PHYSICAL ISSUE 4 0.0002
846 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
847 ABDOMINAL DISCOMFORT 33 0.0002
848 ERECTILE DYSFUNCTION 5 0.0002
849 RESPIRATORY TRACT INFECTION 5 0.0002
850 DERMATITIS 4 0.0002
851 CYANOSIS 3 0.0002
852 SEPSIS 21 0.0002
853 JOINT INJURY 4 0.0002
854 HYPERHIDROSIS 24 0.0002
855 FREQUENT BOWEL MOVEMENTS 5 0.0002
856 DRY MOUTH 15 0.0002
857 ACUTE KIDNEY INJURY 28 0.0002
858 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
859 STOMATITIS 11 0.0002
860 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
861 PROCEDURAL PAIN 5 0.0002
862 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
863 THROAT IRRITATION 8 0.0002
864 THERAPY NON-RESPONDER 8 0.0002
865 CHROMATURIA 4 0.0002
866 HEART RATE IRREGULAR 4 0.0002
867 NEUTROPENIA 24 0.0002
868 PAIN IN JAW 5 0.0002
869 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
870 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
871 NEUTROPHIL COUNT DECREASED 7 0.0002
872 EOSINOPHILIA 3 0.0002
873 HYPERKALAEMIA 6 0.0002
874 AMENORRHOEA 3 0.0002
875 RHINORRHOEA 11 0.0002
876 ABDOMINAL PAIN UPPER 35 0.0002
877 DRUG ERUPTION 3 0.0002
878 TACHYCARDIA 15 0.0002
879 CARDIO-RESPIRATORY ARREST 7 0.0002
880 BLOOD POTASSIUM DECREASED 5 0.0002
881 BLOOD PRESSURE DECREASED 11 0.0002
882 LACRIMATION INCREASED 5 0.0002
883 HAEMATOCHEZIA 9 0.0002
884 OROPHARYNGEAL PAIN 15 0.0002
885 FEMUR FRACTURE 5 0.0002
886 AGRANULOCYTOSIS 3 0.0002
887 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
888 SWOLLEN TONGUE 5 0.0002
889 HEAD INJURY 5 0.0002
890 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 32 0.0002
891 CYSTITIS 5 0.0002
892 TREATMENT FAILURE 13 0.0002
893 HYPOPHAGIA 4 0.0002
894 LETHARGY 9 0.0002
895 EAR PAIN 3 0.0002
896 NAUSEA 121 0.0002
897 KIDNEY INFECTION 3 0.0002
898 MUSCLE SPASMS 28 0.0002
899 UPPER LIMB FRACTURE 3 0.0002
900 PRESCRIBED UNDERDOSE 3 0.0002
901 CYTOKINE RELEASE SYNDROME 3 0.0001
902 BRONCHITIS 11 0.0001
903 EXTRA DOSE ADMINISTERED 6 0.0001
904 THROAT TIGHTNESS 4 0.0001
905 ACUTE HEPATIC FAILURE 2 0.0001
906 OSTEOPOROSIS 6 0.0001
907 RESPIRATORY ARREST 4 0.0001
908 TOOTH LOSS 3 0.0001
909 WOUND 4 0.0001
910 TREMOR 23 0.0001
911 PRODUCT PRESCRIBING ISSUE 3 0.0001
912 PANIC ATTACK 5 0.0001
913 DYSURIA 5 0.0001
914 ORAL PAIN 3 0.0001
915 SNEEZING 3 0.0001
916 CARDIAC ARREST 11 0.0001
917 COLITIS 5 0.0001
918 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
919 PRODUCT DOSE OMISSION ISSUE 38 0.0001
920 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
921 ACUTE MYELOID LEUKAEMIA 2 0.0001
922 TREATMENT NONCOMPLIANCE 7 0.0001
923 BLISTER 7 0.0001
924 PRODUCT USE ISSUE 23 0.0001
925 COMPLETED SUICIDE 10 0.0001
926 DRY SKIN 16 0.0001
927 HOT FLUSH 9 0.0001
928 NASAL CONGESTION 7 0.0001
929 CARDIOVASCULAR DISORDER 3 0.0001
930 MUSCULOSKELETAL PAIN 6 0.0001
931 EAR INFECTION 3 0.0001
932 ERYTHEMA 23 0.0001
933 ACCIDENTAL OVERDOSE 4 0.0001
934 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
935 HYPOKALAEMIA 5 0.0001
936 DIVERTICULITIS 3 0.0001
937 INFLUENZA 12 0.0001
938 ASTHMA 12 0.0001
939 DEHYDRATION 14 0.0001
940 CHILLS 12 0.0001
941 CATARACT 6 0.0001
942 LEUKOPENIA 5 0.0001
943 MYOCARDIAL INFARCTION 17 0.0001
944 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
945 BONE DENSITY DECREASED 3 0.0001
946 HAEMORRHAGE 10 0.0001
947 SEPTIC SHOCK 4 0.0001
948 EXPIRED PRODUCT ADMINISTERED 3 0.0001
949 FUNGAL INFECTION 3 0.0001
950 DRUG INEFFECTIVE 117 0.0001
951 GASTRIC DISORDER 3 0.0001
952 PALPITATIONS 10 0.0001
953 SURGERY 5 0.0001
954 DRY EYE 4 0.0001
955 ACNE 6 0.0001
956 PRURITUS 30 0.0001
957 NEOPLASM MALIGNANT 5 0.0001
958 HYPOTENSION 15 0.0001
959 RASH PRURITIC 4 0.0001
960 CONTUSION 7 0.0001
961 NO ADVERSE EVENT 13 0.0001
962 SKIN EXFOLIATION 6 0.0001
963 EYE PAIN 4 0.0001
964 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
965 RECTAL HAEMORRHAGE 3 0.0001
966 HERPES ZOSTER 4 0.0001
967 ADVERSE DRUG REACTION 6 0.0001
968 ILL-DEFINED DISORDER 4 0.0001
969 SKIN IRRITATION 3 0.0001
970 OCULAR HYPERAEMIA 3 0.0001
971 RASH ERYTHEMATOUS 3 0.0001
972 BLOOD GLUCOSE DECREASED 3 0.0001
973 ECZEMA 3 0.0001
974 ANAPHYLACTIC REACTION 3 0.0001
975 HYPERSENSITIVITY 10 0.0001
976 URTICARIA 9 0.0001
977 CHRONIC KIDNEY DISEASE 4 0.0001
978 MIGRAINE 5 0.0001
979 TOXICITY TO VARIOUS AGENTS 8 0.0000
980 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
981 BREAST CANCER 4 0.0000
982 INJURY 3 0.0000
983 EMOTIONAL DISTRESS 5 0.0000
984 FLUSHING 4 0.0000
985 PSORIASIS 4 0.0000
986 SINUSITIS 3 0.0000
987 OVERDOSE 6 0.0000
988 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
989 INCORRECT DOSE ADMINISTERED 3 0.0000